Single-step QuantiFERON screening of adult contacts: A prospective cohort study of tuberculosis risk

Thorax

Volumn 68, Issue 3, 2013, Pages 240-246

  Haldar, Pranabashis ^a,b   Thuraisingam, Helen ^a   Patel, Hemu ^c   Pereira, Nelun ^c   Free, Robert C ^b   Entwisle, James ^a   Wiselka, Martin ^c   Hoskyns, Edwyn Wren ^c   Monk, Philip ^d   Barer, Michael R ^b,c   Woltmann, Gerrit ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; ISONIAZID; RIFAMPICIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COHORT ANALYSIS; CONTACT EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXPOSURE; FEMALE; HUMAN; INFECTION RISK; INTERFERON GAMMA RELEASE ASSAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; TREATMENT DURATION; TUBERCULOSIS; TUBERCULOSIS CONTROL; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 84873703478     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200956     Document Type: Article

References (22)

1. Barry CE III, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol 2009;7:845-55.
2. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009;33:956-73.
3. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012;12:45-55.
4. Diel R, Loddenkemper R, Nienhaus A. Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis. Chest 2012;142:63-75.
5. Diel R, Loddenkemper R, Niemann S, et al. Negative and positive predictive value of a whole-Blood IGRA for developing active TB - an update. Am J Respir Crit Care Med 2011;183:88-95.
6. Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010;35:1346-53.
7. Mazurek M, Jereb J, Vernon A, et al. Updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
8. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. http://www.nice.org.uk. 1-3-2011. Ref Type: Electronic Citation.
9. National Collaborating Centre for Chronic Conditions. Clinical diagnosis and mangement of tuberculosis and measures for its prevention. http://www.rcplondon.ac.uk/pubs/books/TB/index.asp. 2006. Royal College of Physicians. Ref Type: Electronic Citation.
10. Supply P, Allix C, Lesjean S, et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006;44:4498-510.
11. Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 2010;65:271-6.
12. Office for National Statistics. http://www.ons.gov.uk. 2008. Ref Type: Electronic Citation.
13. Kik SV, Franken WP, Arend SM, et al. Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009;13:820-8.
14. Allix-Beguec C, Fauville-Dufaux M, Supply P. Three-year population-based evaluation of standardized mycobacterial interspersed repetitive-unit-variable- number tandem-repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2008;46:1398-406.
15. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
16. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010;137:952-68.
17. Lee MS, Leung CC, Kam KM, et al. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis 2008;12:281-7.
18. Erkens CG, Kamphorst M, Abubakar I, et al. Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J 2010;36:925-49.
19. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005;54:1-47.
20. Lee SW, Oh DK, Lee SH, et al. Time interval to conversion of interferon-gamma release assay after exposure to tuberculosis. Eur Respir J 2011;37:1447-52.
21. Updated recommendations on interferon gamma release assays for latent tuberculosis infection. An Advisory Committee StatementACS). Can Commun Dis Rep 2008;34(ACS-6):1-13.
22. Rose DN. Benefits of screening for latent Mycobacterium tuberculosis infection. Arch Intern Med 2000;160:1513-21.